Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 09 04:00PM ET
21.67
Dollar change
-0.17
Percentage change
-0.78
%
IndexRUT P/E- EPS (ttm)-2.45 Insider Own14.76% Shs Outstand63.68M Perf Week-3.60%
Market Cap1.67B Forward P/E- EPS next Y-2.45 Insider Trans-0.01% Shs Float62.05M Perf Month15.39%
Income-177.58M PEG- EPS next Q-0.35 Inst Own84.72% Short Float15.04% Perf Quarter6.75%
Sales193.35M P/S8.64 EPS this Y-538.96% Inst Trans2.88% Short Ratio13.25 Perf Half Y1.50%
Book/sh6.17 P/B3.51 EPS next Y-3.43% ROA-24.27% Short Interest9.33M Perf Year-32.83%
Cash/sh5.17 P/C4.19 EPS next 5Y-4.30% ROE-35.06% 52W Range16.67 - 38.00 Perf YTD-39.47%
Dividend Est.- P/FCF- EPS past 5Y- ROI-32.13% 52W High-42.97% Beta1.56
Dividend TTM- Quick Ratio4.11 Sales past 5Y26.65% Gross Margin64.91% 52W Low29.99% ATR (14)1.12
Dividend Ex-Date- Current Ratio4.11 EPS Y/Y TTM-493.26% Oper. Margin-112.86% RSI (14)55.98 Volatility5.04% 5.86%
Employees867 Debt/Eq0.27 Sales Y/Y TTM-3.03% Profit Margin-91.84% Recom1.40 Target Price32.20
Option/ShortYes / Yes LT Debt/Eq0.23 EPS Q/Q39.26% Payout0.00% Rel Volume0.79 Prev Close21.84
Sales Surprise-14.46% EPS Surprise17.84% Sales Q/Q-17.10% EarningsNov 12 BMO Avg Volume704.50K Price21.67
SMA203.32% SMA5013.25% SMA200-0.38% Trades Volume555,600 Change-0.78%
Date Action Analyst Rating Change Price Target Change
Jul-02-24Initiated Leerink Partners Outperform $29
Dec-05-23Initiated KeyBanc Capital Markets Overweight $38
May-05-23Resumed Piper Sandler Overweight $60
Dec-19-22Initiated Goldman Neutral $23
Mar-01-22Initiated Citigroup Buy $55
Nov-19-21Initiated Piper Sandler Overweight $87
Nov-19-21Downgrade Morgan Stanley Overweight → Equal-Weight $82 → $49
Nov-11-21Downgrade BofA Securities Buy → Neutral $80 → $52
Oct-13-21Initiated Berenberg Buy $91
Sep-01-21Upgrade Morgan Stanley Equal-Weight → Overweight $82
Nov-20-24 08:30AM
Nov-19-24 08:30AM
08:30AM
Nov-18-24 08:30AM
Nov-13-24 06:56AM
02:06AM Loading…
02:06AM
12:54AM
Nov-12-24 11:06AM
08:05AM
06:50AM
06:45AM
Nov-11-24 07:10AM
Nov-04-24 08:30AM
Oct-31-24 08:30AM
Oct-23-24 06:01AM
06:01AM Loading…
06:01AM
Oct-17-24 08:30AM
08:30AM
Oct-09-24 06:06AM
06:06AM
Sep-18-24 08:30AM
08:20AM
Aug-28-24 07:06PM
Aug-16-24 08:30AM
Aug-14-24 08:30AM
Aug-05-24 11:20AM
Aug-01-24 12:59PM
Jul-31-24 09:57PM
08:00PM
06:40PM
04:05PM Loading…
04:05PM
Jul-27-24 07:10AM
Jul-26-24 07:00AM
Jul-24-24 10:01AM
Jul-22-24 08:07PM
Jul-17-24 08:58AM
Jul-16-24 08:30AM
Jul-03-24 03:11PM
Jun-14-24 08:30AM
Jun-04-24 11:59AM
May-22-24 08:30AM
May-17-24 08:30AM
May-16-24 07:15AM
May-15-24 08:45AM
May-03-24 03:29PM
01:05PM
May-02-24 03:39AM
May-01-24 10:56PM
05:55PM
05:15PM
04:00PM
Apr-18-24 08:30AM
Apr-10-24 08:30AM
Apr-02-24 04:30PM
Mar-24-24 08:16AM
Mar-20-24 10:27AM
Mar-19-24 08:30AM
Mar-18-24 05:50AM
Mar-01-24 07:30AM
Feb-29-24 01:50PM
10:04AM
Feb-28-24 10:30PM
05:55PM
04:40PM
04:05PM
Feb-26-24 09:15AM
Feb-25-24 09:32PM
Feb-20-24 08:30AM
Feb-19-24 05:13PM
Feb-16-24 08:30AM
Feb-14-24 08:30AM
Jan-19-24 08:30AM
Jan-08-24 07:30AM
Dec-29-23 02:37AM
Dec-19-23 08:30AM
Dec-14-23 07:04AM
Dec-11-23 08:01AM
Dec-10-23 12:00PM
Nov-17-23 08:30AM
Nov-14-23 12:06AM
Nov-09-23 07:11PM
Nov-06-23 08:30AM
Nov-04-23 09:00AM
Nov-02-23 03:59PM
10:33AM
09:00AM
08:15AM
Nov-01-23 06:58PM
06:30PM
04:00PM
Oct-30-23 08:30AM
Oct-27-23 12:31PM
Oct-25-23 06:50AM
Oct-23-23 08:30AM
Oct-18-23 08:30AM
02:59AM
Oct-16-23 05:50AM
Oct-09-23 02:46PM
Oct-08-23 07:19PM
Sep-28-23 05:00PM
Schrodinger, Inc. engages in the provision of chemical simulation software solutions to pharmaceutical industry. It operates through the Software and Drug Discovery business segments. The Software segment sells software to transform drug discovery across the life sciences industry and to customers in materials science industries. The Drug Discovery segment offers diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The company was founded by Richard A. Friesner, William A. Goddard, III and Murco Ringnalda in 1990 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dugan MargaretChief Medical OfficerOct 15 '24Sale17.781,53127,22613,469Oct 16 05:24 PM
Dugan MargaretOfficerOct 15 '24Proposed Sale17.781,53127,226Oct 15 03:16 PM
Lorton Kenneth PatrickEVP, CTO & COO, SoftwareMar 06 '24Option Exercise4.345,57424,19142,061Mar 07 05:05 PM
Porges Geoffrey CraigEVP & CFOMar 04 '24Sale26.353,31587,3605,685Mar 05 05:13 PM
Tran YvonneEVP, CLO & CPOFeb 12 '24Sale28.2975821,44411,963Feb 13 07:39 PM
Abel Robert LorneSee RemarksFeb 12 '24Sale27.551,20533,1989,340Feb 13 07:37 PM
Herman JennySVP & ControllerFeb 12 '24Sale28.2978722,26411,761Feb 13 07:36 PM
Lorton Kenneth PatrickEVP, CTO & COO, SoftwareFeb 12 '24Sale28.2990125,48936,487Feb 13 07:35 PM